Tuesday 23 July 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (TSXV: $WMD.V) (OTC: $SING) (CSE: $MYM.C) (CSE: $BILZ.C) (TSXV: $FAF.V) (NASDAQ: $OPNT) (NYSE: $SNY)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move
(TSXV: $WMD.V) (OTC: $SING) (CSE: $MYM.C) (CSE: $BILZ.C) (TSXV: $FAF.V)
(NASDAQ: $OPNT) (NYSE: $SNY)
Delta, Kelowna, BC –July 23,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/07231WMD-SING-MYM-BILZ-FAF-ONPT-SNY.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In today’s podcast we look at a few early
announcements.
WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) announced that
it has launched CX Industries Inc., a wholly-owned subsidiary that will
specialize in extraction, toll processing and third-party product formulation
from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have
the capacity to process more than 200,000 kgs of biomass at its peak production
in 2020.
“The launch of CX Industries represents
the next step in the evolution of WeedMD. The marriage of consistent low-cost
input material from our cultivation platform with our fully-licensed extraction
hub in Aylmer truly sets us apart. Our
management team is now working with strategic partners to provide a platform
for entrepreneurs and seasoned brands to enter the concentrates market,
building on our history of collaborating successfully with our peers in the
cannabis industry,” said Keith Merker, CEO of WeedMD. “We have a solid reputation
for executing on our production platforms – rooted in our integrity and
transparency, combined with our ability to scale. CX offers world-class extraction and
end-to-end production solutions as the market readies for the launch of
extracts later this year.”
The Company recently announced the
transition of its Aylmer, Ontario facility, now CX Industries, into a
large-scale cannabis extraction and processing hub. Together with its
greenhouse cultivation and outdoor grow that is in full operation at its Strathroy
facility, WeedMD is producing significant low-cost biomass input for
extraction.
SinglePoint Inc. (OTCQB:
SING) announced that
Direct Solar has surpassed everyone’s expectations signing contracts to deploy
$1,709,852 in solar installs over the past 30 days. Bringing the two month
totals to $3,419,312 in contracts, $1,687,886 in revenue and $757,700 in net.
Now that these are in contract they will move to the next phase in planning and
installation. Most of the revenue derived from these contracts will be
recognized throughout the third and fourth quarter. The previous 30 days should
generate approximately $884,117 in gross and $396,159 in net.
Currently Direct Solar is operational in
8 states and continues to expand its residential solar footprint. As the
company has solidified itself and proven the model, many financing companies
have approached the company to start a commercial financing division. The first
financing contract was signed last week and now the company will offer
renewable energy options to commercial operations and have the ability to
finance these larger scale projects. This additional market opens up a
tremendous amount of opportunity in a currently underserved market.
As solar continues to gain traction and
renewable energy becomes a top of mind conversation for many people, studies
continue to pile up. Most recently, CITE research in a nationally
representative poll found that 70% of people said they would support of version
a California’s solar mandate. This is not far off from the 2016 Pew Research
study that found 89% of Americans supported expanding rooftop solar.
In addition, according to Zion Market
Research, the global Solar Panel Market accounted for USD $30.8 Billion in 2016
and is expected to reach USD $57.3 billion by 2022 growing at a CAGR of 10.9%
between 2017 and 2022.
MYM Nutraceuticals Inc. (CSE:
MYM) (OTCBB:
MYMMF) announced that
its joint venture company (MYM owns 50%), BioHemp Naturals Growing &
Farming Ltd. ("BioHemp"), has signed a non-binding Letter of Intent
("LOI") for the sale of $25 million of CBD-rich hemp biomass.
"I am truly excited to share that
our sales team has secured a LOI for $25 million, representing nearly half of
our remaining forecasted CBD-rich hemp biomass," said Howard Steinberg,
CEO of MYM. "The recipient of the biomass represents a consortium of Canada's
largest cannabis LP's and is a great vote of confidence to the quality of
BioHemp's Canadian grown CBD-rich hemp."
Fire & Flower Holdings Corp. and
its wholly-owned subsidiary Fire &
Flower Inc. (TSXV:
FAF), today
announced that it has received its licence to operate
a cannabis retail store in Whitehorse, Yukon from the Yukon Liquor Corporation,
Cannabis Licensing.
Upon opening, this will be the 24th
Fire & Flower branded, licensed cannabis store and will be located at #110,
80 Chilkoot Way, Whitehorse, Yukon.
In addition to continuing to deliver on
Fire & Flower's rapid near-term rollout schedule, the receipt of a licence
in the Yukon territory demonstrates Fire & Flower's ability to successfully
open cannabis retail stores in provinces across Canada where private cannabis
retail is permitted.
"The receipt of a cannabis retail
store licence in the Yukon demonstrates Fire & Flower's ability to
successfully open retail stores rapidly across multiple jurisdictions with
varying regulatory requirements," shared Trevor Fencott, Fire &
Flower's Chief Executive Officer. "The opening of a Fire & Flower
store in this northern Canadian market will enable us to further understand
cannabis purchasing preferences through our proprietary Hifyre digital platform,
that in turn will allow us to better tailor our experience to local markets. We
look forward to becoming members of the Whitehorse community and welcoming
local customers into our store."
Fire & Flower will announce the
opening date and time of the Whitehorse store at its earliest opportunity on
its website at www.fireandflower.com/locations/.
Ignite International, Ltd., a
wholly owned subsidiary of Ignite
International Brands, Ltd. (CSE:BILZ), today
announced that it has signed a joint venture
agreement with Grupo Ensejal, S.A. de C.V. The joint venture, which will
operate as a newly formed legal entity, will encompass convenience, specialty
retail, pharmacy and e-commerce retail channels.
"Ignite is quickly becoming a global
powerhouse brand and expanding to our neighbors to the south was a natural next
step. The creation of the Mexican joint venture gives Ignite first mover
positioning in Mexico to build relationships and trust with retailers and
buyers," said Jim McCormick, President of Ignite International Brands,
Ltd., "Grupo Ensejal is the perfect partner for us as they get the power
of Dan Bilzerian's global reach and understand the power of smart marketing
when creating brands."
The joint venture will draw on Ignite's
marketing expertise and the brand recognition of the Ignite trademark, the
iconic goat's skull logo and founder Dan Bilzerian who has amassed a global
social media fan base of over 44 million followers across the leading social
media platforms.
Added Roberto Celaya Burruel, Partner of
Grupo Ensejal, "We are excited to be a part of the rapid expansion of the
Ignite brand and bringing it to Mexico. We have been watching what Dan
Bilzerian has been doing with Ignite over the past year in the United States
and we are confident we can continue the buzz for our neighbors to the
north."
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a
specialty pharmaceutical company developing medicines for addictions and drug
overdose, today
announced that it has signed an agreement with Sanofi (NYSE:SNY) to
manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the
treatment of Acute Cannabinoid Overdose (ACO). Opiant intends to reformulate
drinabant, a high affinity, selective cannabinoid receptor antagonist, for
parenteral administration in an emergency department setting. Opiant licensed
exclusive global rights from Sanofi for the development and commercialization
of drinabant for the emergency treatment of ACO. The manufacturing will be
performed in Sanofi Újpest site (Hungary) acting as a Contract Development and
Manufacturing Organization (CDMO).
“This agreement marks an important
milestone in our partnership with Sanofi and the OPNT004 development program
and supply chain,” said Roger Crystal, M.D., Chief Executive Officer of Opiant.
“This further enhances our position as a leader in developing medicines for the
treatment of addiction and drug overdose.”
ACO is most often linked to the ingestion
of both “edibles”, products containing large quantities of D9-tetrahydrocannabinol
(THC) that are often sold as brownies, cookies, and candies, and synthetic
cannabinoids (sold with names such as “K2” and “Spice”) that are more potent,
easily obtained, and less expensive than cannabis containing products. It is
estimated that ACO resulted in more than one million emergency department
visits in the United States in 2016, and is expected to rise with increasing
legalization of cannabis in North America. Features of ACO can include
psychosis, hallucinations, nausea and
vomiting, as well as feelings of paranoia, agitation, panic and anxiety. These
symptoms often require emergency medical attention and can take from hours to days
to fully resolve. There are currently no approved treatments for ACO.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Monday 22 July 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (CSE: $AGRO.C) (CSE: $GRIN.C) (CSE: $CHM.C) (CSE: $SLNG.C) (TSXV: $RIV.V) (TSX: $WEED.TO) (NYSE: $CGC)(CSE: $MWM.C) (OTC: $TGRR)
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (CSE:
$AGRO.C) (CSE: $GRIN.C) (CSE: $CHM.C) (CSE: $SLNG.C) (TSXV: $RIV.V) (TSX: $WEED.TO)
(NYSE: $CGC)(CSE: $MWM.C) (OTC: $TGRR)
Delta, Kelowna, BC –July
22, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news
source covering leading sectors including marijuana and hemp stocks and its
potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/07221AGRO-GRIN-CHM-SLNG-RIV-WEED-CGC-MWM-TGRR.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In today’s podcast we look at a few early
announcements.
Agrios Global Holdings Ltd. (CSE:
AGRO) (OTCQB:
AGGHF) provided
an update on the progress of its subsidiary Agrios
Asia.
Following the recent receipt of a hemp
cultivation permit, Agrios Asia hired a project director based in Kunming,
Yunnan Province, China to oversee the cultivation operations and hemp stalk
pre-process build out. The subsidiary has begun cultivation of industrial hemp
at the Yunnan Han Ma Biological Industrial Hemp Cultivation Base. Agrios Asia expects its first harvest in
October 2019.
Stephanie Wong, Managing Director of
Agrios Asia explained, "The aim of establishing the hemp stalk
pre-processing plant is to provide consistent quality raw materials to produce
our research products such as hemp straw and biodegradable single use dining
ware. We are still waiting for advice from the research institutes on the exact
requirement of the raw materials to determine the treatment process and
corresponding equipment required."
Kunming University of Science and
Technology ("KMUST") has completed the first stage of hemp straw
research, involving the extraction techniques to prepare hemp pulp, and filed a
Chinese patent for a "short-process for the extraction of hemp
fibers". The second stage of research is underway and focuses on the
preparation of pulp with the optimal mix of hemp core fiber and hemp hurds
fiber. Preliminary results are promising with a gross pulp yield approaching
50%.
Once hemp pulp can be manufactured into
hemp paper, the next stage will be the development of the manufacturing process
to make environmentally friendly, biodegradable hemp straws from the hemp paper
and then expanding the product scope to other dining ware such as cups, plates
and bowls.
Grown Rogue International Inc. (CSE:GRIN) (OTC:GRUSF) announced
today that the US Patent and Trademark Office
awarded Grown Rogue full patent for its innovative "Certified Fresh"
Nitrogen Sealed Pre-rolls. The Nitrogen Sealing Process eliminates oxygen
through nitrogen injection which preserves the freshness of the flower. The
process also vacuum seals the product to lock in freshness.
"There
are dozens of premium pre-rolls in the cannabis market, but there is only one
innovation that seals with nitrogen and ensures freshness," said Obie
Strickler, CEO and Co-Founder of Grown Rogue.
Several
cannabis companies have used nitrogen to seal cannabis in various applications
but Grown Rogue is the first to develop a solution to seal a glass tube with
nitrogen. "Customers can see the quality of product through the glass and
with the nitrogen infusion will know that they can enjoy a truly fresh cannabis
experience," added Mr. Strickler.
Grown
Rogue first introduced the "Certified Fresh" Nitrogen Sealed
Pre-rolls in January 2018 which drove sales and brand awareness in the Oregon
market. Since then, the Nitrogen Sealed Pre-Rolls have become a symbol of the
companies' commitment to Innovation in a competitive marketplace. The company
has developed nitrogen sealed 3.5 gram glass flower jars which is also an
industry first, but is not currently seeking a patent for that innovation.
"Customers
have a lot of choices when it comes to pre-rolls and cannabis products in
general and our innovative "Certified Fresh" Nitrogen Sealed products
speak to our unique differentiation in product development and our commitment
to empowering consumers to enhance life experiences through cannabis,"
added Rob Rigg, EVP Marketing at Grown Rogue.
Several
companies have approached Grown Rogue to license the Nitrogen Pre-Rolls in
other markets across the United States. "Our plan is to license the
technology and process to partners in areas where we do not have near term
expansion plans," said Mr. Strickler. "Like Tesla or Apple, we want
to launch technologies across the world that positively impact the consumer
experience," added Mr. Strickler.
Chemistree Technology Inc. (CSE:
CHM) (OTCQB:
CHMJF) announced that
through a wholly owned U.S. subsidiary, the Company has finalized its
investment into Applied Cannabis Sciences of New Jersey ("ACS"), a
New Jersey-based medical vertically integrated applicant, previously announced
as a letter of intent (press release dated April 15, 2019).
ACS will be submitting its application in
the upcoming New Jersey round of Request for Applications (RFA), which was
released Monday, July15, 2019 by the New Jersey Department of Health. The State
will issue 24 new permits, comprising of 15 dispensary permits, 5 cultivation
permits, and 4 vertically integrated permits. All applications are to be
submitted by August 22, 2019. ACS placed in the top 20 applicants in the last
permitting round, narrowly missing out on receiving a license at that time.
ACS will be participating in this current
round be a part of the expansion of New
Jersey's medical program which has set a goal of increasing registered patient
count to over 200,000 as well as anticipating the adult-use market if decided
by voters in a 2020 referendum. The
application, if successful, will provide ACS with a fully integrated
cultivation, manufacturing/processing and retail sales license in the state of
New Jersey. Currently, there are only 12 facilities servicing the 49,000
patients enrolled in New Jersey medicinal cannabis program.
"Completing this investment with ACS
and being on the ground floor towards expanding New Jersey's medical marijuana
program marks a significant step forward in our Company's East Coast expansion
plans," stated Karl Kottmeier, President of Chemistree. "We expect, along with ACS' leading
cannabis experts and track record, that we will be able to secure this highly
coveted and valuable State license."
Director Nico Escondido said, "The
entire team at ACS is very excited to have solidified our partnership with
Chemistree. The goals of both entities are keenly aligned, with the objectives
of serving both the patients and communities in which we operate being our top
priority. This partnership enables us to disseminate our mission across North
America, while also creating a hub for cannabis research and development here
on the Eastern seaboard. We look forward to a successful application in our
great State of New Jersey and working with the members of Chemistree to build something
of incredible value for both our patients and the cannabis industry."
SLANG Worldwide Inc. (CSE:
SLNG), a leading global cannabis consumer
packaged goods company with a robust portfolio of renowned brands distributed
across 2,600 stores in 12 US states, today
announced that it is entering the European Union,
starting with Greece, through a partnership with Global Cannabis Corp.
("GCC").
GCC's wholly owned subsidiary, GCC Pharma
S.A. is one of the first companies to receive a medical cannabis installation
license from the government of Greece for cannabis cultivation, processing and
manufacturing. SLANG has worked closely with GCC throughout the application
process and has been instrumental in assisting GCC with the design and content
of its license application. In exchange for the contribution of SLANG's
specialized expertise, and continuing support, SLANG has been granted a 20%
interest in GCC.
SLANG intends to leverage its
relationship with GCC to introduce its brand portfolio to the European Union,
with products in market in 2020. The Company expects to collect licensing
revenues in Greece similar to its partnerships in the United States.
"The addition of GCC to SLANG's
partner network is a major milestone in our global expansion strategy,"
said Peter Miller, CEO of SLANG. "This partnership can help lead to the
awareness of our brands in new and key markets while leveraging the capital-light
growth model that Slang has optimized in the United States."
Greece has a population of 10.7 million
and an annual health care expenditure of €14.3 billion with a cannabis market
expected to reach €1.9 billion by 2028 (Source: Prohibition Partners – The
European Cannabis Report, 4th Edition, January 2019). Medical cannabis use was
legalized in Greece in June 2017. Shortly thereafter, in March 2018, lawmakers
approved a law allowing the farming and processing of medical cannabis in
Greece. With its ideal climate and agricultural expertise, Greece also has the
opportunity to be a prominent supplier of cannabis and cannabis products
throughout the EU where permitted.
"We are extremely pleased to be
amongst the first recipients of a cannabis license in Greece, a strategic entry
point into the rapidly growing EU region with a population exceeding 740
million people," said Loannis Papadopoulos, CEO of GCC. "SLANG's
diverse product portfolio and proven extraction and manufacturing expertise
will be key to the timely introduction of our offering to medical cannabis
patients."
Canopy
Rivers Inc. (TSXV:
RIV) (OTC:
CNPOF) announced that
its 49%-owned joint venture, PharmHouse Inc., has received a cultivation
licence from Health Canada. PharmHouse will be immediately commencing
operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to
ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of
2019 to deliver low-cost and high-quality cannabis and cannabis derivative
products to the Canopy Rivers ecosystem of partners, both domestically and
internationally.
"This is a significant corporate
milestone for Canopy Rivers. We believe the PharmHouse platform to be the
epitome of value creation for our shareholders, and exposure to this project
represents an investment opportunity only available through Canopy
Rivers," said Narbe Alexandrian, President and CEO of Canopy Rivers. "Together with the expertise of agriculture
industry titan Paul Mastronardi, along with our team of ag-specialist joint
venture partners, Canopy Rivers has helped finance, construct, and prepare for
licence one of the largest, state-of-the-art cannabis facilities in the world,
and has already backed it with multi-year contracts with internationally
-focused industry leaders that we expect will translate into significant cash
flow and profitability," continued Alexandrian.
Founded by Canopy Rivers and the
principals and operators of North American agriculture and produce conglomerate
Mastronardi Produce Limited, PharmHouse is a newly -built 1.3 million sq. ft
facility located in Leamington, Ontario.
Its transformative approach to production integrates a high degree of
automation, lean manufacturing processes, and commercial agricultural best
practices. The result is a large-scale
greenhouse operationally optimized for commercial -scale, low -cost cannabis
production that is designed to comply with Good Manufacturing Practices.
Through the Joint Venture Partners, PharmHouse has access to plant science,
automation, and logistical expertise that has been developed over multiple
generations by a continental leader and garnered recognition and support from
some of the largest retailers and wholesalers throughout Canada and the United
States.
PharmHouse has already entered into
commercial offtake agreements for a combined 50% of its 2020 production with
industry leaders Canopy Growth Corp
(TSX:
WEED) (NYSE:
CGC) and TerrAscend Corp (CSE:
TER) (OTCQX:
TRSSF), validating the Canopy Rivers ecosystem
model and supporting the international brand and distribution platforms of the
Company and its partners.
"This licence is a monumental
achievement for PharmHouse, a joint venture that I believe represents the
future of cannabis production, distribution, and technological
innovation," said Paul Mastronardi, CEO of Mastronardi Produce Limited
and, in his personal capacity, the largest individual shareholder in the
PharmHouse joint venture. "We look forward to continuing to lend our
proven operational, marketing, and distribution expertise to PharmHouse, and
collaborating with Canopy Rivers to continue building our planned global cannabis
platform."
Micron Waste Technologies Inc. (CSE:
MWM) (OTC:
MICWF), a leading developer of waste treatment
systems for cannabis and food waste, has
announced that its shares are now eligible for
electronic clearing and settlement in the United States through the Depository
Trust Company ("DTC"). DTC is a subsidiary of the Depository Trust
& Clearing Corporation, a U.S. company that manages the electronic clearing
and settlement of publicly traded companies. DTC services provide cost benefits
for investors and brokers trading Canadian securities in the United States.
"Micron intends to become a unique
ancillary supplier to the rapidly growing American cannabis sector. In
particular, Micron aims to service multi-state operators expanding their cultivation
footprints and producing more waste under stricter regulatory and environmental
oversight," said Alfred Wong, Micron President and CEO. "DTC
eligibility is a natural evolution for our Company - our shareholders will
benefit from increased liquidity and a larger shareholder base in addition to
greater convenience and execution speeds."
Cannavore™ Update
Micron's Cannavore waste system prototype
continues to meet milestones at Aurora Cannabis Inc.'s Mountain facility near
Calgary, where is it undergoing full throughput processing and stress testing.
The world's first closed-loop cannabis waste processing system was designed to
Aurora's specifications to be a clean technology solution to process organic
waste generated from the growth and cultivation of cannabis, while mitigating
concerns about the potential environmental impact.
Micron currently has additional Cannavore
systems under construction, working with strategic partner BC Research Inc.
Micron's Organivore™ food waste system prototype is currently being upgraded
with new technology developed for the Cannavore.
Tiger Reef, Inc. (OTC:
TGRR), an emerging leader in cost-efficient
clean energy solutions targeting the CBD and legal Cannabis markets and
producer of ultra-premium rum under the Tiger Reef® brand designation, announced the
signing of a Letter of Intent for the acquisition of Atlas Solar Holdings, LLC.
The move represents a powerful step by
the Company as it aggressively pursues a dominant position as a provider of
tailored energy solutions targeting the $492 million market comprised of energy
demand from cannabis and CBD producers.
“In our conversations with cannabis and
CBD producers, the most important factor on these guys’ minds is how to
compress energy costs,” commented J. Scott Sitra, Tiger Reef’s President and
CEO. “According to our research, no one else out there is pursuing a pure-play
strategy targeting tailored solutions to that rapidly growing problem. We have
that solution and we are scaling up to make a run at dominating the niche.”
Management notes that Atlas Solar
currently owns and operates a total of 34 state-of-the-art industrial solar
installations producing over 420,000 KWh of solar electricity annually. As a
result of this production level, Atlas Solar earns over 420 solar renewable
energy credits (SRECs) per year. In addition, Atlas is producing positive net
cash flow of approximately $120,000 annually from operations directly related
to solar power generation.
“As we have previously communicated to
investors, one of the most important priorities with our newly accessed funding
is the rapid expansion of our primary operations as the leading solution for
the cannabis and CBD energy space,” continued Mr. Sitra. “Atlas Solar
represents a perfect example of our sense of a strong ROI deployment of those
funds because it directly augments the ammunition we have as we aggressively
market our solution to companies that represent an exciting combination: they
are both cash-rich and in sore need of a long-term path adjustment for energy
costs, which is precisely what we have to offer.”
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...